Modulation of cytotoxic drug activity by dipyridamole-Reference-Cited by-同舟云学术

Modulation of cytotoxic drug activity by dipyridamole

Published:1990-12 Issue: Volume:17 Page:57-65
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Schmoll Hans-Joachim,Harstrick Andreas,Köhne-Wömpner Claus-Henning,Schöber Christoph,Wilke Hansjochen,Poliwoda Hubert

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference45 articles.

1. Potentiation of some anticancer agents by dipyridamole against drug sensitive and drug resistant cancer cell lines;Asoh;Jpn. J. Cancer Res.,1989

2. Phase I trial of a 120 hour infusion of 5-fluorouracil, leucovorin and dipyridamole;Bailey,1990

3. Detection of p-glycoprotein in ovarian cancer: a molecular marker associated with multi drug resistance;Bell;J. Clin. Oncol.,1985

4. Enhancement of anthracycline growth inhibition in parent and multidrugs resistant Chinese hamster ovary cells by cyclosporin A and its analogues;Chambers;Cancer Res.,1989

5. Augmentation of 1-beta-D-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibition of drug efflux;Chan;Cancer Res.,1989

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleoside Transport Inhibitors: Structure−Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of α1-Acid Glycoprotein;Journal of Medicinal Chemistry;2011-03-02

2. Resistance-Modifying Agents. 11. Pyrimido[5,4-d]pyrimidine Modulators of Antitumor Drug Activity. Synthesis and Structure−Activity Relationships for Nucleoside Transport Inhibition and Binding to α1-Acid Glycoprotein;Journal of Medicinal Chemistry;2004-08-26

3. Resistance-modifying agents. Part 7: 2,6-disubstituted-4,8-dibenzylaminopyrimido[5,4- d ]pyrimidines that inhibit nucleoside transport in the presence of α 1 -acid glycoprotein (AGP);Bioorganic & Medicinal Chemistry Letters;2000-03

4. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced α 1-acid glycoprotein binding;British Journal of Cancer;1999-07-09

5. Dipyridamole increases VP16 growth inhibition, accumulation and retention in parental and multidrug-resistant CHO cells;British Journal of Cancer;1996-04